medicines
Info Justice | 14-Jul-2017
The cool reasoning of the Canadian Supreme Court does not acknowledge or reference “external” pressures or the Eli Lilly v. Canada ISDS case. However, courts do not decide cases in a vacuum. This case seems to have been decided in a pressure cooker.
APWLD | 13-Jul-2017
The ’No RCEP’ campaign urges governments to consider the adverse impact of the mega free trade agreement
Focus on the Global South | 1-Jun-2017
In the recent “RCEP 18th Round of Talks,” members of civil society organizations and social movements presented their positions vis-à-vis the RCEP.
Inquirer.net | 18-May-2017
RCEP negotiations have been highly conspiratorial and undemocratic, with all 18 rounds of trade discussions held in secret and no reports shared with the public
People Over Profit | 12-May-2017
#NoRCEP week of actions at the 18th TNC Meeting of the Regional Comprehensive Economic Partnership
Forum on FTAs | 8-May-2017
RCEP magnifies existing inequalities and discriminates against women, indigenous peoples, people living with HIV or other illnesses, people with disabilities,rural communities, farmers and workers
keywords:
actions | resistance,
India,
investor-state disputes | ISDS,
medicines,
Philippines,
RCEP,
women
AFTINET | 3-May-2017
ISDS is increasingly being used by global corporations to challenge health, environment and other public interest laws.
Forum against FTAs | 27-Apr-2017
Trade unions, farmers groups, health activists, and other people’s movements are planning to organise a series of events to put pressure on the Government of India to withdraw from RCEP negotiations.
AGEFI | 13-Apr-2017
Le géant bâlois est accusé d’avoir "menacé" le ministère colombien du Commerce et de l’Industrie de recourir à un tribunal d’arbitrage international.
Public Eye | 12-Apr-2017
Confidential documents obtained by Public Eye show that Novartis has threatened Colombia with international investment arbitration under its BIT with Switzerland to avoid the issuance of a compulsory license
